389 related articles for article (PubMed ID: 23142793)
1. Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease--dermatitis herpetiformis.
Lytton SD; Antiga E; Pfeiffer S; Matthias T; Szaflarska-Poplawska A; Ulaganathan VK; Placek W; Fabbri P; Hall R; Caproni M
Clin Chim Acta; 2013 Jan; 415():346-9. PubMed ID: 23142793
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet.
Rose C; Armbruster FP; Ruppert J; Igl BW; Zillikens D; Shimanovich I
J Am Acad Dermatol; 2009 Jul; 61(1):39-43. PubMed ID: 19344979
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
Agardh D
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against neo-epitope of microbial and human transglutaminase complexes as biomarkers of childhood celiac disease.
Agardh D; Matthias T; Wusterhausen P; Neidhöfer S; Heller A; Lerner A
Clin Exp Immunol; 2020 Mar; 199(3):294-302. PubMed ID: 31663117
[TBL] [Abstract][Full Text] [Related]
5. Novel assay for detecting celiac disease-associated autoantibodies in dermatitis herpetiformis using deamidated gliadin-analogous fusion peptides.
Kasperkiewicz M; Dähnrich C; Probst C; Komorowski L; Stöcker W; Schlumberger W; Zillikens D; Rose C
J Am Acad Dermatol; 2012 Apr; 66(4):583-8. PubMed ID: 21840083
[TBL] [Abstract][Full Text] [Related]
6. IgA anti-epidermal transglutaminase autoantibodies: a sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients.
Borroni G; Biagi F; Ciocca O; Vassallo C; Carugno A; Cananzi R; Campanella J; Bianchi PI; Brazzelli V; Corazza GR
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):836-41. PubMed ID: 22672004
[TBL] [Abstract][Full Text] [Related]
7. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases.
Gatselis NK; Zachou K; Norman GL; Tzellas G; Speletas M; Gabeta S; Germenis A; Koukoulis GK; Dalekos GN
Clin Chim Acta; 2012 Oct; 413(19-20):1683-8. PubMed ID: 22643316
[TBL] [Abstract][Full Text] [Related]
8. Comparison of commercially available serologic kits for the detection of celiac disease.
Naiyer AJ; Hernandez L; Ciaccio EJ; Papadakis K; Manavalan JS; Bhagat G; Green PH
J Clin Gastroenterol; 2009 Mar; 43(3):225-32. PubMed ID: 18724250
[TBL] [Abstract][Full Text] [Related]
9. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.
Monzani A; Rapa A; Fonio P; Tognato E; Panigati L; Oderda G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):55-60. PubMed ID: 21694536
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients.
Mozo L; Gómez J; Escanlar E; Bousoño C; Gutiérrez C
J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):50-5. PubMed ID: 22197936
[TBL] [Abstract][Full Text] [Related]
11. Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis.
Kumar V; Jarzabek-Chorzelska M; Sulej J; Rajadhyaksha M; Jablonska S
Clin Immunol; 2001 Mar; 98(3):378-82. PubMed ID: 11237562
[TBL] [Abstract][Full Text] [Related]
12. [Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease].
Sabelnikova EA; Parfenov AI; Krums LM; Gudkova RB; Sagynbaeva VE; Bykova SV
Ter Arkh; 2014; 86(2):39-43. PubMed ID: 24772506
[TBL] [Abstract][Full Text] [Related]
13. Celiac disease serology in dermatitis herpetiformis. Which is the best option for detecting gluten sensitivity?
Sugai E; Smecuol E; Niveloni S; Vázquez H; Label M; Mazure R; Czech A; Kogan Z; Mauriño E; Bai JC
Acta Gastroenterol Latinoam; 2006 Dec; 36(4):197-201. PubMed ID: 17225447
[TBL] [Abstract][Full Text] [Related]
14. Serum reactivity in dermatitis herpetiformis: an international multicentre study.
Boch K; Heck F; Hammers CM; Antiga E; Caproni M; Juhl D; Goletz S; Horváth ON; Huilaja L; Khil'chenko S; Sina C; Tasanen K; Vassileva S; Schlumberger W; Zillikens D; Shahid M; Drenovska K; Zone JJ; Koszorú K; Fechner K; Dähnrich C; König IR; Schmidt E
Clin Exp Dermatol; 2023 Dec; 49(1):53-57. PubMed ID: 37793183
[TBL] [Abstract][Full Text] [Related]
15. Association between levels of IgA antibodies to tissue transglutaminase and gliadin-related nonapeptides in dermatitis herpetiformis.
Gornowicz-Porowska J; Bowszyc-Dmochowska M; Seraszek-Jaros A; Kaczmarek E; Dmochowski M
ScientificWorldJournal; 2012; 2012():363296. PubMed ID: 22547981
[TBL] [Abstract][Full Text] [Related]
16. Are antiepidermal transglutaminase antibodies titre correlated with dermatitis herpetiformis lesions during the disease follow-up?
Cozzani E; Pappalardo F; Gasparini G; Gallo F; Drago F; Parodi A
G Ital Dermatol Venereol; 2018 Oct; 153(5):609-612. PubMed ID: 27845514
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
Sayed SK; Imam HM; Mahran AM; Refaiy AM
Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406
[TBL] [Abstract][Full Text] [Related]
18. Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis.
Koop I; Ilchmann R; Izzi L; Adragna A; Koop H; Barthelmes H
Am J Gastroenterol; 2000 Aug; 95(8):2009-14. PubMed ID: 10950050
[TBL] [Abstract][Full Text] [Related]
19. Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study.
Aita A; Rossi E; Basso D; Guariso G; Bozzato D; Pelloso M; Pescarin M; Zambon CF; Navaglia F; Greco E; Gasparetto M; Fogar P; Padoan A; Moz S; Plebani M
Clin Chim Acta; 2013 Jun; 421():202-7. PubMed ID: 23542610
[TBL] [Abstract][Full Text] [Related]
20. A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescent findings.
Beutner EH; Baughman RD; Austin BM; Plunkett RW; Binder WL
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):329-32. PubMed ID: 10901714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
